Invus Opportunities
New York City, New Yorkinvus.com
Overview
Invus Opportunities is an investment firm that partners with market-leading management teams and investors in private transactions globally. It focuses on non-control, private company investments and typically makes equity investments of $10-50M in a range of industries including fintech, marketplace/eCommerce, healthcare, SaaS, and other tech-enabled sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| Kailera Therapeutics | Oct 2025 | Series B | Co-investor |
| Soufflé Therapeutics | Oct 2025 | Series A | Co-investor |
| Brius | May 2025 | Series B | - |
| Rain | Apr 2025 | Series B | Co-investor |
Key People
Matthew Maslow
Principal Public Equities Head Of Capital Markets
Nadim Razzouk
Principal
Robert Mikesell
Principal - Trader
Shubham Chatterjee
Biotech Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.